SlidesetHIVRSVCOVID-19Viral Infections & Inflammation Workshop 2022Abstract 1: Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality - Joseph RoccoView Slideset
ANAvindra NathMDSlidesetHIVRSVCOVID-19Viral Infections & Inflammation Workshop 2022Neurologic Sequelae of Acute Viral Infections - Avindra Nath, MDView Slideset
MPMirko PaiardiniPhDSlidesetHIVRSVCOVID-19Viral Infections & Inflammation Workshop 2022Characterizing and Targeting Acute Inflammation Following SARS-CoV-2 Infection- Mirko Paiardini, PhDView Slideset
YKYogen KanthiMD, FAHA, FSVMSlidesetHIVRSVCOVID-19Viral Infections & Inflammation Workshop 2022Coagulopathy in Acute Viral Infections - COVID-19 - Yogen Kanthi, MD, FAHA, FSVMView Slideset
JLJudy LiebermanMD, PhDSlidesetHIVRSVCOVID-19Viral Infections & Inflammation Workshop 2022Inflammasome Activation in Acute COVID-19 - Judy Lieberman, MD, PhDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionWhat is the Pipeline? (Drugs) - Anchalee Avihingsanon, MD, PhDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionCON - Jakkrapatara Boonruang, MDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionImplementation Considerations - Heather-Marie Schmidt, BMedSc (Hon), MPH, PhDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionClinical Considerations: What Have We Learned? - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipHIVView Slideset
GBGeorg BehrensMD, PhDSlidesetHIVRSVHIV Glasgow 2022 Symposium - The Devil Wears GP120Clinical Data from the GP120 Inhibitor Temsavir and its Relevance to Immune Reconstitution and HIV Associated Inflammation - Georg Behrens, MD, PhDView Slideset
JTJohn ThornhillPhD, MB BCh, BMed SciSlidesetHIVRSVHIV Glasgow 2022 Symposium - The Devil Wears GP120Immune Dysregulation – a Remaining Challenge in HIV Medicine - John Thornhill, PhD, MB BCh, BMed SciView Slideset
